<unk>  is an anti-neoplastic agent that is FDA approved for the treatment of patients with advanced prostate cancer.   Common adverse reactions include injection site reactions (e.g., pain, erythema, swelling, or induration), hot flashes, increased weight, fatigue, and increases in serum levels of transaminases and gamma-glutamyltransferase (GGT),asthenia, fever, night sweats, Nausea, Dizziness, headache and insomnia.
Degarelix
Talbutal
Ingenol mebutate
Abarelix
Nafarelin
Arbutin
Deslorelin
Estropipate 